To include your compound in the COVID-19 Resource Center, submit it here.

Mallinckrodt divests hemostasis portfolio for $185M

In an effort to refine its pipeline, specialty pharmaceutical company Mallinckrodt plc (NYSE:MNK) sold surgical site bleeding products Preveleak Surgical Sealant and

Read the full 224 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE